In a significant regulatory overhaul aimed at streamlining administrative workflows and enhancing transparency, the Central Drugs Standard Control Organization (CDSCO) has announced the implementation of an automated re-application process for the issuance of Compliance Certificates (CoCs) for medical device manufacturers. This initiative is set to